TrialBritish journal of haematology2026

A comprehensive analysis of pirtobrutinib in Chinese patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL): Results from the phase 3 study BRUIN CLL-321.

Shuhua Yi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.